The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
Our genetic therapies program consists of both basic and translational research projects. Translational projects are facilitated by the Belfer Gene Therapy Core Facility, a clinical vector production laboratory which has produced adenovirus and adeno-associated virus vectors for numerous human studies.
Our Personalized Medicine program utilizes the latest technologies to characterize genetic variants in cells and tissues on a genome-wide basis for projects aimed at identifying candidate genes associated with complex genetic diseases.
As part of Weill Cornell, the Department of Genetic Medicine is committed to excellence in research, education, and the advancement of science.